Root Cause Clinical Course · Module 3 of 10 · 3 lessons · 32 min

GI health and the microbiome

Learning objectives

  • Apply Rome IV criteria and recognize alarm features that need endoscopy or referral.
  • Use breath testing and treatment for SIBO with an understanding of their limits.
  • Recommend fiber, peppermint oil and probiotics where the evidence supports them.
Lesson 1 of 3

Assessing GI symptoms

IBS (Rome IV): recurrent abdominal pain at least 1 day a week over the last 3 months, with 2 or more of: related to defecation, a change in stool frequency, or a change in stool form. Symptoms should have started at least 6 months before diagnosis. Subtype by stool form: IBS-C, IBS-D, or mixed.

IBS is a positive diagnosis, not just a diagnosis of exclusion. A limited workup is enough for most patients without alarm features:

TestWhenWhy
CBCMost patientsAnemia suggests another cause
Celiac serology (tTG-IgA, total IgA)IBS-D or mixedCeliac disease mimics IBS
Fecal calprotectin or CRPDiarrheaScreens for inflammatory bowel disease
Giardia stool testDiarrhea with exposure riskTreatable infection
ColonoscopyAlarm features, or due for age-based screening (45+)Rule out cancer and IBD
Lesson 2 of 3

SIBO and the microbiome

Small intestinal bacterial overgrowth (SIBO) is more likely with PPIs, opioids, diabetes or other motility disorders, prior abdominal surgery, and scleroderma.

  • Breath testing (glucose or lactulose) is the usual test. North American consensus: a hydrogen rise of 20 ppm or more within 90 minutes is positive; methane of 10 ppm or more suggests intestinal methanogen overgrowth, often with constipation. False positives and negatives are common, so interpret in context.
  • Treatment: rifaximin is FDA-approved for IBS-D (550 mg three times a day for 14 days) and is commonly used for SIBO. Fix the cause where you can: deprescribe PPIs that aren't needed, review opioids, and manage diabetes.
  • Commercial stool microbiome panels describe which bacteria are present, but there are no validated cutoffs that guide treatment. They are not part of guideline-based care.

Long-term PPI use deserves review at every visit. Many patients can taper (halve the dose for 2 to 4 weeks, then stop, using on-demand antacids or H2 blockers for rebound symptoms). Keep PPIs for Barrett's esophagus, severe esophagitis, and high bleeding risk.

Lesson 3 of 3

Fiber, probiotics and food

InterventionEvidenceHow to use
Soluble fiber (psyllium)Recommended for IBS symptoms (ACG)Start 3 to 4 g a day and increase slowly; insoluble bran can worsen bloating
Peppermint oilConditional recommendation for global IBS symptoms (ACG)Enteric-coated capsules; may worsen reflux
Low-FODMAP dietLimited trial recommended for IBS (ACG)Phased, ideally with a dietitian
ProbioticsAGA advises against for most GI conditions outside trialsPossible exception: specific strains to prevent C. difficile with antibiotics
Fermented foodsRaised microbiome diversity and lowered inflammatory markers in a small trialYogurt, kefir, kimchi, sauerkraut as tolerated
Gut-directed CBT or hypnotherapyRecommended for IBS (ACG)Works well alongside diet changes

Clinical pearls

  • Check celiac serology before labeling IBS-D.
  • Fecal calprotectin helps separate IBS from inflammatory bowel disease in patients with diarrhea.
  • Before treating "SIBO," ask why it might be there: PPIs, opioids, motility problems or surgery.

Red flags: refer or work up first

  • Rectal bleeding, iron deficiency anemia, unintentional weight loss, or nocturnal diarrhea.
  • New symptoms at 45 or older, or a family history of colorectal cancer, IBD or celiac disease.
  • Difficulty swallowing, persistent vomiting, or fever with abdominal pain.

Case

A 29-year-old has had cramping and loose stools for a year, better after bowel movements. CBC is normal. She has no alarm features. She asks for a comprehensive stool microbiome test.

Show discussion

She likely meets Rome IV criteria for IBS-D. Check celiac serology and fecal calprotectin. A stool microbiome panel won't change management. Start with soluble fiber, a trial of peppermint oil or a dietitian-guided low-FODMAP diet, and consider gut-directed CBT. Rifaximin is an option if symptoms persist.

Question 1: Which finding is an alarm feature that warrants further workup in suspected IBS?

Question 2: What does current AGA guidance say about probiotics?

References
  • Lacy BE, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021.
  • Mearin F, Lacy BE, et al. Bowel Disorders (Rome IV). Gastroenterology. 2016.
  • Rezaie A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017.
  • Pimentel M, et al. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020.
  • Su GL, et al. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020.
  • Targownik LE, et al. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors. Gastroenterology. 2022.
  • Wastyk HC, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021.
Patient handout · plain language

Caring for your gut

  • Add fiber slowly. A spoonful of psyllium (like Metamucil) in water each day is a good start.
  • Drink plenty of water, especially as you add fiber.
  • Try fermented foods you enjoy, such as yogurt or kefir.
  • Eat slowly, and move your body every day. Walking helps digestion.
  • Stress affects the gut. Calming practices can ease symptoms.

Call us or get care soon if you see blood in your stool, lose weight without trying, wake up at night with diarrhea, or have trouble swallowing.

Taking acid reducers (like omeprazole) every day? Ask us whether you still need them. Don't stop suddenly on your own.

General education for licensed clinicians and the public. Not medical advice, and not a substitute for clinical judgment, current guidelines, or a visit with a licensed provider. Product names are examples, not endorsements. Drug doses, coding rules and guidance change; check current labeling, payer rules and guidelines before acting. Book a visit with Empowered Health.